LU J61 Pill - pink round, 6mm
Pill with imprint LU J61 is Pink, Round and has been identified as Drospirenone, Ethinyl Estradiol and Levomefolate Calcium drospirenone 3 mg / ethinyl estradiol 0.02 mg / levomefolate calcium 0.451 mg. It is supplied by Lupin Pharmaceuticals, Inc.
Drospirenone/ethinyl estradiol/levomefolate calcium is used in the treatment of Acne; Premenstrual Dysphoric Disorder; Birth Control and belongs to the drug class contraceptives. Not for use in pregnancy. Drospirenone/ethinyl estradiol/levomefolate calcium drospirenone 3 mg / ethinyl estradiol 0.02 mg / levomefolate calcium 0.451 mg is not a controlled substance under the Controlled Substances Act (CSA).
Images for LU J61
Drospirenone, Ethinyl Estradiol and Levomefolate Calcium
- Imprint
- LU J61
- Strength
- drospirenone 3 mg / ethinyl estradiol 0.02 mg / levomefolate calcium 0.451 mg
- Color
- Pink
- Size
- 6.00 mm
- Shape
- Round
- Availability
- Prescription only
- Drug Class
- Contraceptives
- Pregnancy Category
- X - Not for use in pregnancy
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- Lupin Pharmaceuticals, Inc.
- National Drug Code (NDC)
- 68180-0894
- Inactive Ingredients
-
ascorbic acid,
croscarmellose sodium,
ferric oxide yellow,
ferric oxide red,
hypromelloses,
lactose monohydrate,
low substituted hydroxypropyl cellulose,
magnesium stearate,
polyethylene glycol,
corn starch,
magnesium silicate,
titanium dioxide
Note: Inactive ingredients may vary.
More about drospirenone / ethinyl estradiol / levomefolate calcium
- Check interactions
- Compare alternatives
- Pricing & coupons
- Reviews (260)
- Drug images
- Side effects
- Dosage information
- During pregnancy
- Drug class: contraceptives
- En español
Patient resources
- Drospirenone, ethinyl estradiol, and levomefolate drug information
- Drospirenone, ethinyl estradiol, and levomefolate (Advanced Reading)
Other brands
Beyaz, Tydemy, Rajani, Safyral
Professional resources
Other brands
Beyaz, Tydemy, Rajani, Safyral
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.